thisdrug what a medicine's name tells you

WHO naming stem · anywhere in the name · 14 listed names

retin

This page was written with AI.

retinol derivatives

WHO's definition, quoted as written in the 2024 stem book

5 of 14 names appear in these lists: 5 in the US list (FDA Drugs@FDA) and 1 in the EU central list (EMA); 5 have national brands in at least one EU/EEA country.

Names only. This page is about retin as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as retin, without hyphens, which means it can sit anywhere in a name. So the letters retin sit anywhere in the name (retin).

All 14 names WHO lists under retin

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 5 of 14 names appear in these lists: 5 in the US list (FDA Drugs@FDA) and 1 in the EU central list (EMA); 5 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.

  1. acitretin
    US brands: SORIATANE (discontinued in FDA listings)
    EU (central) brands: none found
  2. alitretinoin
    US brands: PANRETIN
    EU (central) brands: Panretin (withdrawn)
  3. doretinel
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  4. etretin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  5. etretinate
    US brands: TEGISON (discontinued in FDA listings)
    EU (central) brands: none found
  6. fenretinide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  7. isotretinoin
    US brands: ABSORICA, ABSORICA LD, AMNESTEEM, CLARAVIS, MYORISAN, ZENATANE, ACCUTANE (discontinued in FDA listings), SOTRET (discontinued in FDA listings)
    EU (central) brands: none found
  8. motretinide
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  9. pelretin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  10. peretinoin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  11. retinol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  12. tretinoin
    US brands: ALTRENO, ATRALIN, AVITA, RENOVA, RETIN-A, RETIN-A MICRO, RETIN-A-MICRO, TRETINOIN MICROSPHERE, VESANOID (discontinued in FDA listings)
    in combination: TRI-LUMA with fluocinolone acetonide + hydroquinone; TWYNEO with benzoyl peroxide; VELTIN with clindamycin; ZIANA with clindamycin; SOLAGE (discontinued in FDA listings) with mequinol
    EU (central) brands: none found
  13. tretinoin tocoferil
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  14. zuretinol acetate
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)

US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.

EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.

EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.

Names with these letters that are not retinol derivatives

WHO lists these 3 names under retin, but says the stem is not used in its meaning here: group (b) of Part IV of the 2024 stem book, “INN in which the preferred stem has been used, but not in accordance with its definition”. The letters are marked where they sit; WHO’s note, where it gives one, is quoted as written. In these names, WHO’s definition of retin does not apply.

  1. noretynodrel
  2. secretin
  3. trethinium tosilate

Decode another name

Decoded

etretin

Listed INNCarries the WHO stem retin

  • retinend of the nameWHO lists it hereWHO definition: retinol derivatives

“etretin” is an INN that WHO lists under retin in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of retin (Part II B) and the 14 names (Part IV, group (a)), and the 3 not in accordance with it (group (b)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.

Made with AI tools. · Privacy